GLAUKOS Corp

For the period ended Dec 31, 2023. Filed Feb 23, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 23, 2024

GKOS$236.19-1.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flow****s


· · Year ended
· · December 31,
· · 2023 · · 2022 · · 2021

Operating Activities · · · · ·
Net loss	$(134,661)	$(99,195)	$(49,593)
Adjustments to reconcile net loss to net cash (used in) provided operating activities:
Depreciation	8,742	6,664	4,749
Amortization of intangible assets	24,912	24,912	24,912
Amortization of right-of-use lease assets	4,324	4,370	4,760
Amortization of debt issuance costs	1,373	1,373	1,373
Deferred income tax benefit	(120)	(54)	(1,029)
Loss (gain) on disposal of fixed assets	893	(24)	7
Stock-based compensation	43,528	38,561	30,146
Unrealized foreign currency (gains) losses	(980)	2,242	2,313
(Accretion of discount) amortization of premium on short-term investments	(1,685)	731	1,028
Other liabilities	3,049	785	2,465
Acquired in-process R&D acquired through the issuance of common stock	3,000	—	—
Changes in operating assets and liabilities:
Accounts receivable, net	(3,843)	(3,138)	1,700
Inventory	(4,830)	(15,472)	(7,703)
Prepaid expenses and other current assets	(885)	(1,720)	(3,054)
Accounts payable and accrued liabilities	1,305	7,210	12,448
Other assets	(1,880)	(328)	186
Net cash (used in) provided by operating activities	(57,758)	(33,083)	24,708
Investing activities
Purchases of property and equipment	(20,248)	(30,265)	(47,785)
Purchases of short-term investments	(265,587)	(59,256)	(215,285)
Proceeds from sales and maturities of short-term investments	303,100	135,157	206,916
Proceeds from disposal of property and equipment	—	151	3
Investment in company-owned life insurance	(3,170)	(1,008)	(2,081)
Net cash provided by (used in) investing activities	14,095	44,779	(58,232)
Financing activities
Proceeds from exercise of stock options	12,748	3,577	26,124
Share purchases under Employee Stock Purchase Plan	6,278	5,630	4,817
Payments of employee taxes related to vested restricted stock units	(3,273)	(2,730)	(3,690)
Proceeds from tenant improvement allowance	—	301	12,668
Principal paid on finance lease	(711)	(527)	(659)
Net cash provided by financing activities	15,042	6,251	39,260
Effect of exchange rate changes on cash and cash equivalents	1,341	(1,468)	(1,774)
Net (decrease) increase in cash, cash equivalents and restricted cash	(27,280)	16,479	3,962
Cash, cash equivalents and restricted cash at beginning of period	126,603	110,124	106,162
Cash, cash equivalents and restricted cash at end of period	$99,323	$126,603	$110,124
Supplemental schedule of noncash investing and financing activities
Purchases of property and equipment included in accounts payable and accrued liabilities	$1,333	$3,797	$2,263

Supplemental disclosures of cash flow information
Taxes paid, net of refunds	$1,557	$522	$272
Interest paid on convertible senior notes	$7,906	$7,906	$7,907
Other interest paid	$4,348	$4,434	$4,074

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.